Remeditex Ventures LLC

10% owner at APOLLO CAPITAL GROUP, INC. · on record since Dec 30, 2016
10% owner at BELLICUM PHARMACEUTICALS, INC · on record since Dec 23, 2014
10% owner at MedGen, Inc. · on record since Feb 13, 2017
10% owner at Yarrow Bioscience, Inc. · on record since Jan 29, 2018
10% owner at Soliton, Inc. · on record since Jun 19, 2019

Insider trading activity of Remeditex Ventures LLC

Transactions on record: 24; since Dec 19, 2014

Open-market buys: 4; $2.7M

Open-market sells: 0

Companies traded: 3; last filing Dec 17, 2021

Figures computed from official regulatory filings — .

Companies where Remeditex Ventures LLC has traded

Soliton, Inc.8 tx · $209.2M · Dec 17, 2021
Yarrow Bioscience, Inc.7 tx · $1.7M · Jan 29, 2018
BELLICUM PHARMACEUTICALS, INC9 tx · Dec 23, 2014

Track record of Remeditex Ventures LLC

Statistical track record

Free account

Open-market buys: 6

Last buy: Jun 30, 2020

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Remeditex Ventures LLC

Co-insiders of Remeditex Ventures LLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Soliton, Inc.Listing unverified	Dec 17, 2021	OtherD (derivative)	-170,808	—	n/a (No price was disclosed in the filing)		SEC
Soliton, Inc.Listing unverified	Dec 17, 2021	Other	-9,214,277	22.60 USD	$208.2M		SEC
Soliton, Inc.Listing unverified	Dec 17, 2021	OtherD (derivative)	-250,000	—	n/a (No price was disclosed in the filing)		SEC
Soliton, Inc.Listing unverified	Jul 1, 2020	Buy	120,481	8.30 USD	$1M	conv 22	SEC
Soliton, Inc.Listing unverified	Oct 15, 2019	BuyD (derivative)	170,808	—	n/a (No price was disclosed in the filing)		SEC
Soliton, Inc.Listing unverified	Oct 15, 2019	Buy	155,280	—	n/a (No price was disclosed in the filing)	conv 18	SEC
Soliton, Inc.Listing unverified	Jun 19, 2019	Buy	357,143	—	n/a (No price was disclosed in the filing)	conv 35First in 12mo	SEC
Soliton, Inc.Listing unverified	Jun 19, 2019	BuyD (derivative)	250,000	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
Yarrow Bioscience, Inc.Security delisted	Jan 29, 2018	OtherD (derivative)	-7,150	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Yarrow Bioscience, Inc.Security delisted	Jan 29, 2018	Other	2,650	—	n/a (No price was disclosed in the filing)		SEC
Yarrow Bioscience, Inc.Security delisted	Jan 29, 2018	OtherD (derivative)	-2,351,097	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Yarrow Bioscience, Inc.Security delisted	Jan 29, 2018	Other	871,583	—	n/a (No price was disclosed in the filing)		SEC
Yarrow Bioscience, Inc.Security delisted	Jan 29, 2018	Buy	100,000	17.00 USD	$1.7M	conv 52ClusterFirst in 12mo	SEC
Yarrow Bioscience, Inc.Security delisted	Jan 29, 2018	Other	304,576	—	n/a (No price was disclosed in the filing)		SEC
Yarrow Bioscience, Inc.Security delisted	Jan 29, 2018	OtherD (derivative)	-821,596	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Dec 23, 2014	Other	1,359,297	—	n/a (No price was disclosed in the filing)		SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Dec 23, 2014	Other	159,444	—	n/a (No price was disclosed in the filing)		SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Dec 23, 2014	Other	245,299	—	n/a (No price was disclosed in the filing)		SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Dec 23, 2014	OtherD (derivative)	-271,055	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Dec 23, 2014	Other	43,563	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Dec 23, 2014	OtherD (derivative)	-417,009	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Dec 23, 2014	OtherD (derivative)	-2,310,806	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Dec 19, 2014	OtherD (derivative)	271,055	—	n/a (No price was disclosed in the filing)		SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Dec 19, 2014	OtherD (derivative)	-271,055	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Soliton, Inc.Listing unverified	Dec 17, 2021	OtherD (derivative)	-170,808	—	n/a (No price was disclosed in the filing)		SEC
Soliton, Inc.Listing unverified	Dec 17, 2021	Other	-9,214,277	22.60 USD	$208.2M		SEC
Soliton, Inc.Listing unverified	Dec 17, 2021	OtherD (derivative)	-250,000	—	n/a (No price was disclosed in the filing)		SEC
Soliton, Inc.Listing unverified	Jul 1, 2020	Buy	120,481	8.30 USD	$1M	conv 22	SEC
Soliton, Inc.Listing unverified	Oct 15, 2019	BuyD (derivative)	170,808	—	n/a (No price was disclosed in the filing)		SEC
Soliton, Inc.Listing unverified	Oct 15, 2019	Buy	155,280	—	n/a (No price was disclosed in the filing)	conv 18	SEC
Soliton, Inc.Listing unverified	Jun 19, 2019	Buy	357,143	—	n/a (No price was disclosed in the filing)	conv 35First in 12mo	SEC
Soliton, Inc.Listing unverified	Jun 19, 2019	BuyD (derivative)	250,000	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
Yarrow Bioscience, Inc.Security delisted	Jan 29, 2018	OtherD (derivative)	-7,150	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Yarrow Bioscience, Inc.Security delisted	Jan 29, 2018	Other	2,650	—	n/a (No price was disclosed in the filing)		SEC
Yarrow Bioscience, Inc.Security delisted	Jan 29, 2018	OtherD (derivative)	-2,351,097	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Yarrow Bioscience, Inc.Security delisted	Jan 29, 2018	Other	871,583	—	n/a (No price was disclosed in the filing)		SEC
Yarrow Bioscience, Inc.Security delisted	Jan 29, 2018	Buy	100,000	17.00 USD	$1.7M	conv 52ClusterFirst in 12mo	SEC
Yarrow Bioscience, Inc.Security delisted	Jan 29, 2018	Other	304,576	—	n/a (No price was disclosed in the filing)		SEC
Yarrow Bioscience, Inc.Security delisted	Jan 29, 2018	OtherD (derivative)	-821,596	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Dec 23, 2014	Other	1,359,297	—	n/a (No price was disclosed in the filing)		SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Dec 23, 2014	Other	159,444	—	n/a (No price was disclosed in the filing)		SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Dec 23, 2014	Other	245,299	—	n/a (No price was disclosed in the filing)		SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Dec 23, 2014	OtherD (derivative)	-271,055	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Dec 23, 2014	Other	43,563	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Dec 23, 2014	OtherD (derivative)	-417,009	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Dec 23, 2014	OtherD (derivative)	-2,310,806	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Dec 19, 2014	OtherD (derivative)	271,055	—	n/a (No price was disclosed in the filing)		SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Dec 19, 2014	OtherD (derivative)	-271,055	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC